Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology

Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse outcomes. In this study, we investigated the factors associated with in-hospital outcomes among hospitalized patients with COVID-19 and AKI. In this multicenter retrospective obser...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-08, Vol.16 (8), p.e0256023
Hauptverfasser: Arikan, Hakki, Ozturk, Savas, Tokgoz, Bulent, Dursun, Belda, Seyahi, Nurhan, Trabulus, Sinan, Islam, Mahmud, Ayar, Yavuz, Gorgulu, Numan, Karadag, Serhat, Gok, Mahmut, Akcali, Esra, Bora, Feyza, Aydın, Zeki, Altun, Eda, Ahbap, Elbis, Polat, Mehmet, Soypacacı, Zeki, Oguz, Ebru Gok, Koyuncu, Sumeyra, Colak, Hulya, Sahin, İdris, Dolarslan, Murside Esra, Helvacı, Ozant, Kurultak, Ilhan, Eren, Zehra, Dheir, Hamad, Ogutmen, Melike Betul, Taymez, Dilek Guven, Genek, Dilek Gibyeli, Ozkurt, Sultan, Bakır, Elif Ari, Yuksel, Enver, Sahutoglu, Tuncay, Oto, Ozgur Akin, Boz, Gulsah, Sengul, Erkan, Kara, Ekrem, Tuglular, Serhan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 8
container_start_page e0256023
container_title PloS one
container_volume 16
creator Arikan, Hakki
Ozturk, Savas
Tokgoz, Bulent
Dursun, Belda
Seyahi, Nurhan
Trabulus, Sinan
Islam, Mahmud
Ayar, Yavuz
Gorgulu, Numan
Karadag, Serhat
Gok, Mahmut
Akcali, Esra
Bora, Feyza
Aydın, Zeki
Altun, Eda
Ahbap, Elbis
Polat, Mehmet
Soypacacı, Zeki
Oguz, Ebru Gok
Koyuncu, Sumeyra
Colak, Hulya
Sahin, İdris
Dolarslan, Murside Esra
Helvacı, Ozant
Kurultak, Ilhan
Eren, Zehra
Dheir, Hamad
Ogutmen, Melike Betul
Taymez, Dilek Guven
Genek, Dilek Gibyeli
Ozkurt, Sultan
Bakır, Elif Ari
Yuksel, Enver
Sahutoglu, Tuncay
Oto, Ozgur Akin
Boz, Gulsah
Sengul, Erkan
Kara, Ekrem
Tuglular, Serhan
description Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse outcomes. In this study, we investigated the factors associated with in-hospital outcomes among hospitalized patients with COVID-19 and AKI. In this multicenter retrospective observational study, we evaluated the characteristics and in-hospital renal and patient outcomes of 578 patients with confirmed COVID-19 and AKI. Data were collected from 34 hospitals in Turkey from March 11 to June 30, 2020. AKI definition and staging were based on the Kidney Disease Improving Global Outcomes criteria. Patients with end-stage kidney disease or with a kidney transplant were excluded. Renal outcomes were identified only in discharged patients. The median age of the patients was 69 years, and 60.9% were males. The most frequent comorbid conditions were hypertension (70.5%), diabetes mellitus (43.8%), and chronic kidney disease (CKD) (37.6%). The proportions of AKI stages 1, 2, and 3 were 54.0%, 24.7%, and 21.3%, respectively. 291 patients (50.3%) were admitted to the intensive care unit. Renal improvement was complete in 81.7% and partial in 17.2% of the patients who were discharged. Renal outcomes were worse in patients with AKI stage 3 or baseline CKD. The overall in-hospital mortality in patients with AKI was 38.9%. In-hospital mortality rate was not different in patients with preexisting non-dialysis CKD compared to patients without CKD (34.4 versus 34.0%, p = 0.924). By multivariate Cox regression analysis, age (hazard ratio [HR] [95% confidence interval (95%CI)]: 1.01 [1.0-1.03], p = 0.035], male gender (HR [95%CI]: 1.47 [1.04-2.09], p = 0.029), diabetes mellitus (HR [95%CI]: 1.51 [1.06-2.17], p = 0.022) and cerebrovascular disease (HR [95%CI]: 1.82 [1.08-3.07], p = 0.023), serum lactate dehydrogenase (greater than two-fold increase) (HR [95%CI]: 1.55 [1.05-2.30], p = 0.027) and AKI stage 2 (HR [95%CI]: 1.98 [1.25-3.14], p = 0.003) and stage 3 (HR [95%CI]: 2.25 [1.44-3.51], p = 0.0001) were independent predictors of in-hospital mortality. Advanced-stage AKI is associated with extremely high mortality among hospitalized COVID-19 patients. Age, male gender, comorbidities, which are risk factors for mortality in patients with COVID-19 in the general population, are also related to in-hospital mortality in patients with AKI. However, preexisting non-dialysis CKD did not increase in-hospital mortality rate among AKI patients. Renal problems continue i
doi_str_mv 10.1371/journal.pone.0256023
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2560041019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A671434801</galeid><doaj_id>oai_doaj_org_article_8ae9bf2af4fe41fdbc04abe994245f2b</doaj_id><sourcerecordid>A671434801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-ed26569e91355cdbb1a1118781e43097f8129bdeda0f652d2002208022aa29653</originalsourceid><addsrcrecordid>eNqNk9uO0zAQhiMEYpfCGyCwhITgosWnuAkXSFU5VVqpEix7aznxpHE3jYvtIMpL8Mo4NLtq0F6gSHbifPOP57cnSZ4SPCNsTt5sbeda1cz2toUZpqnAlN1LzknO6FRQzO6fvJ8lj7zfYpyyTIiHyRnjbJ4yIc6T38taOVUGcMYHU3qkWo1sF0q7A49shVTZBUDXRrdwQKbddq6fUG393gTVmF-g0XJ9tXo_JTnaq2CgDf4tWqBd10TB-AUO-dDpAyoOKNSALjt3bXyNvC0NhEOfpIV97WxjN4fHyYNKNR6eDPMk-fbxw-Xy8_Ri_Wm1XFxMS5HTMAVNRSpyyAlL01IXBVGEkGyeEeAM5_MqIzQvNGiFK5FSTTGmFGdxUIrmImWT5PlRd99YLwcvvextxJzg6NwkWR0JbdVW7p3ZKXeQVhn5d8G6jVQuVtiAzBTkRUVVxSvgpNJFibkqIM855WlFi6j1bsjWFTvQvStONSPR8Z_W1HJjf8iMpZwLEQVeDQLOfu_AB7kzvoSmUS3Y7rhvmsczzSL64h_07uoGaqNiAaatbMxb9qJyIeaEM55hEqnZHVR8NOxMGS9eZeL6KOD1KCAyAX6Gjeq8l6uvX_6fXV-N2ZcnbA2qCbW3TReMbf0Y5EewdNZ7B9WtyQTLvm9u3JB938ihb2LYs9MDug26aRT2B12qE_4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2560041019</pqid></control><display><type>article</type><title>Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Arikan, Hakki ; Ozturk, Savas ; Tokgoz, Bulent ; Dursun, Belda ; Seyahi, Nurhan ; Trabulus, Sinan ; Islam, Mahmud ; Ayar, Yavuz ; Gorgulu, Numan ; Karadag, Serhat ; Gok, Mahmut ; Akcali, Esra ; Bora, Feyza ; Aydın, Zeki ; Altun, Eda ; Ahbap, Elbis ; Polat, Mehmet ; Soypacacı, Zeki ; Oguz, Ebru Gok ; Koyuncu, Sumeyra ; Colak, Hulya ; Sahin, İdris ; Dolarslan, Murside Esra ; Helvacı, Ozant ; Kurultak, Ilhan ; Eren, Zehra ; Dheir, Hamad ; Ogutmen, Melike Betul ; Taymez, Dilek Guven ; Genek, Dilek Gibyeli ; Ozkurt, Sultan ; Bakır, Elif Ari ; Yuksel, Enver ; Sahutoglu, Tuncay ; Oto, Ozgur Akin ; Boz, Gulsah ; Sengul, Erkan ; Kara, Ekrem ; Tuglular, Serhan</creator><contributor>Reboldi, Gianpaolo</contributor><creatorcontrib>Arikan, Hakki ; Ozturk, Savas ; Tokgoz, Bulent ; Dursun, Belda ; Seyahi, Nurhan ; Trabulus, Sinan ; Islam, Mahmud ; Ayar, Yavuz ; Gorgulu, Numan ; Karadag, Serhat ; Gok, Mahmut ; Akcali, Esra ; Bora, Feyza ; Aydın, Zeki ; Altun, Eda ; Ahbap, Elbis ; Polat, Mehmet ; Soypacacı, Zeki ; Oguz, Ebru Gok ; Koyuncu, Sumeyra ; Colak, Hulya ; Sahin, İdris ; Dolarslan, Murside Esra ; Helvacı, Ozant ; Kurultak, Ilhan ; Eren, Zehra ; Dheir, Hamad ; Ogutmen, Melike Betul ; Taymez, Dilek Guven ; Genek, Dilek Gibyeli ; Ozkurt, Sultan ; Bakır, Elif Ari ; Yuksel, Enver ; Sahutoglu, Tuncay ; Oto, Ozgur Akin ; Boz, Gulsah ; Sengul, Erkan ; Kara, Ekrem ; Tuglular, Serhan ; Reboldi, Gianpaolo</creatorcontrib><description>Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse outcomes. In this study, we investigated the factors associated with in-hospital outcomes among hospitalized patients with COVID-19 and AKI. In this multicenter retrospective observational study, we evaluated the characteristics and in-hospital renal and patient outcomes of 578 patients with confirmed COVID-19 and AKI. Data were collected from 34 hospitals in Turkey from March 11 to June 30, 2020. AKI definition and staging were based on the Kidney Disease Improving Global Outcomes criteria. Patients with end-stage kidney disease or with a kidney transplant were excluded. Renal outcomes were identified only in discharged patients. The median age of the patients was 69 years, and 60.9% were males. The most frequent comorbid conditions were hypertension (70.5%), diabetes mellitus (43.8%), and chronic kidney disease (CKD) (37.6%). The proportions of AKI stages 1, 2, and 3 were 54.0%, 24.7%, and 21.3%, respectively. 291 patients (50.3%) were admitted to the intensive care unit. Renal improvement was complete in 81.7% and partial in 17.2% of the patients who were discharged. Renal outcomes were worse in patients with AKI stage 3 or baseline CKD. The overall in-hospital mortality in patients with AKI was 38.9%. In-hospital mortality rate was not different in patients with preexisting non-dialysis CKD compared to patients without CKD (34.4 versus 34.0%, p = 0.924). By multivariate Cox regression analysis, age (hazard ratio [HR] [95% confidence interval (95%CI)]: 1.01 [1.0-1.03], p = 0.035], male gender (HR [95%CI]: 1.47 [1.04-2.09], p = 0.029), diabetes mellitus (HR [95%CI]: 1.51 [1.06-2.17], p = 0.022) and cerebrovascular disease (HR [95%CI]: 1.82 [1.08-3.07], p = 0.023), serum lactate dehydrogenase (greater than two-fold increase) (HR [95%CI]: 1.55 [1.05-2.30], p = 0.027) and AKI stage 2 (HR [95%CI]: 1.98 [1.25-3.14], p = 0.003) and stage 3 (HR [95%CI]: 2.25 [1.44-3.51], p = 0.0001) were independent predictors of in-hospital mortality. Advanced-stage AKI is associated with extremely high mortality among hospitalized COVID-19 patients. Age, male gender, comorbidities, which are risk factors for mortality in patients with COVID-19 in the general population, are also related to in-hospital mortality in patients with AKI. However, preexisting non-dialysis CKD did not increase in-hospital mortality rate among AKI patients. Renal problems continue in a significant portion of the patients who were discharged.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0256023</identifier><identifier>PMID: 34375366</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acute Kidney Injury - etiology ; Acute Kidney Injury - pathology ; Age ; Aged ; Biology and Life Sciences ; Care and treatment ; Cerebrovascular diseases ; Chronic kidney failure ; Clinical outcomes ; Comorbidity ; Confidence intervals ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - mortality ; COVID-19 - pathology ; COVID-19 - virology ; Creatinine ; Cytokines ; Diabetes mellitus ; Dialysis ; Education ; End-stage renal disease ; Female ; Funding ; Gender ; Health risks ; Health sciences ; Hemodialysis ; Hospital Mortality ; Hospital patients ; Hospitalization ; Hospitals ; Humans ; Hypertension ; Intensive care ; Intensive Care Units ; Internal medicine ; Kidney diseases ; Kidney transplantation ; Kidneys ; L-Lactate dehydrogenase ; L-Lactate Dehydrogenase - blood ; Lactate dehydrogenase ; Lactic acid ; Male ; Males ; Medical prognosis ; Medicine ; Medicine and Health Sciences ; Middle Aged ; Mortality ; Nephrology ; Observational studies ; Patient outcomes ; Patients ; Proportional Hazards Models ; Regression analysis ; Retrospective Studies ; Risk analysis ; Risk Factors ; SARS-CoV-2 - isolation &amp; purification ; Severe acute respiratory syndrome coronavirus 2 ; Severity of Illness Index ; Sex Factors ; Software ; Statistical analysis ; Supervision ; Turkey ; University faculty ; Viral diseases</subject><ispartof>PloS one, 2021-08, Vol.16 (8), p.e0256023</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Arikan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Arikan et al 2021 Arikan et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-ed26569e91355cdbb1a1118781e43097f8129bdeda0f652d2002208022aa29653</citedby><cites>FETCH-LOGICAL-c692t-ed26569e91355cdbb1a1118781e43097f8129bdeda0f652d2002208022aa29653</cites><orcidid>0000-0003-4607-9220 ; 0000-0002-1382-2439 ; 0000-0003-1284-916X ; 0000-0003-0946-0823 ; 0000-0001-6195-1932</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354466/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354466/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34375366$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Reboldi, Gianpaolo</contributor><creatorcontrib>Arikan, Hakki</creatorcontrib><creatorcontrib>Ozturk, Savas</creatorcontrib><creatorcontrib>Tokgoz, Bulent</creatorcontrib><creatorcontrib>Dursun, Belda</creatorcontrib><creatorcontrib>Seyahi, Nurhan</creatorcontrib><creatorcontrib>Trabulus, Sinan</creatorcontrib><creatorcontrib>Islam, Mahmud</creatorcontrib><creatorcontrib>Ayar, Yavuz</creatorcontrib><creatorcontrib>Gorgulu, Numan</creatorcontrib><creatorcontrib>Karadag, Serhat</creatorcontrib><creatorcontrib>Gok, Mahmut</creatorcontrib><creatorcontrib>Akcali, Esra</creatorcontrib><creatorcontrib>Bora, Feyza</creatorcontrib><creatorcontrib>Aydın, Zeki</creatorcontrib><creatorcontrib>Altun, Eda</creatorcontrib><creatorcontrib>Ahbap, Elbis</creatorcontrib><creatorcontrib>Polat, Mehmet</creatorcontrib><creatorcontrib>Soypacacı, Zeki</creatorcontrib><creatorcontrib>Oguz, Ebru Gok</creatorcontrib><creatorcontrib>Koyuncu, Sumeyra</creatorcontrib><creatorcontrib>Colak, Hulya</creatorcontrib><creatorcontrib>Sahin, İdris</creatorcontrib><creatorcontrib>Dolarslan, Murside Esra</creatorcontrib><creatorcontrib>Helvacı, Ozant</creatorcontrib><creatorcontrib>Kurultak, Ilhan</creatorcontrib><creatorcontrib>Eren, Zehra</creatorcontrib><creatorcontrib>Dheir, Hamad</creatorcontrib><creatorcontrib>Ogutmen, Melike Betul</creatorcontrib><creatorcontrib>Taymez, Dilek Guven</creatorcontrib><creatorcontrib>Genek, Dilek Gibyeli</creatorcontrib><creatorcontrib>Ozkurt, Sultan</creatorcontrib><creatorcontrib>Bakır, Elif Ari</creatorcontrib><creatorcontrib>Yuksel, Enver</creatorcontrib><creatorcontrib>Sahutoglu, Tuncay</creatorcontrib><creatorcontrib>Oto, Ozgur Akin</creatorcontrib><creatorcontrib>Boz, Gulsah</creatorcontrib><creatorcontrib>Sengul, Erkan</creatorcontrib><creatorcontrib>Kara, Ekrem</creatorcontrib><creatorcontrib>Tuglular, Serhan</creatorcontrib><title>Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse outcomes. In this study, we investigated the factors associated with in-hospital outcomes among hospitalized patients with COVID-19 and AKI. In this multicenter retrospective observational study, we evaluated the characteristics and in-hospital renal and patient outcomes of 578 patients with confirmed COVID-19 and AKI. Data were collected from 34 hospitals in Turkey from March 11 to June 30, 2020. AKI definition and staging were based on the Kidney Disease Improving Global Outcomes criteria. Patients with end-stage kidney disease or with a kidney transplant were excluded. Renal outcomes were identified only in discharged patients. The median age of the patients was 69 years, and 60.9% were males. The most frequent comorbid conditions were hypertension (70.5%), diabetes mellitus (43.8%), and chronic kidney disease (CKD) (37.6%). The proportions of AKI stages 1, 2, and 3 were 54.0%, 24.7%, and 21.3%, respectively. 291 patients (50.3%) were admitted to the intensive care unit. Renal improvement was complete in 81.7% and partial in 17.2% of the patients who were discharged. Renal outcomes were worse in patients with AKI stage 3 or baseline CKD. The overall in-hospital mortality in patients with AKI was 38.9%. In-hospital mortality rate was not different in patients with preexisting non-dialysis CKD compared to patients without CKD (34.4 versus 34.0%, p = 0.924). By multivariate Cox regression analysis, age (hazard ratio [HR] [95% confidence interval (95%CI)]: 1.01 [1.0-1.03], p = 0.035], male gender (HR [95%CI]: 1.47 [1.04-2.09], p = 0.029), diabetes mellitus (HR [95%CI]: 1.51 [1.06-2.17], p = 0.022) and cerebrovascular disease (HR [95%CI]: 1.82 [1.08-3.07], p = 0.023), serum lactate dehydrogenase (greater than two-fold increase) (HR [95%CI]: 1.55 [1.05-2.30], p = 0.027) and AKI stage 2 (HR [95%CI]: 1.98 [1.25-3.14], p = 0.003) and stage 3 (HR [95%CI]: 2.25 [1.44-3.51], p = 0.0001) were independent predictors of in-hospital mortality. Advanced-stage AKI is associated with extremely high mortality among hospitalized COVID-19 patients. Age, male gender, comorbidities, which are risk factors for mortality in patients with COVID-19 in the general population, are also related to in-hospital mortality in patients with AKI. However, preexisting non-dialysis CKD did not increase in-hospital mortality rate among AKI patients. Renal problems continue in a significant portion of the patients who were discharged.</description><subject>Acute Kidney Injury - etiology</subject><subject>Acute Kidney Injury - pathology</subject><subject>Age</subject><subject>Aged</subject><subject>Biology and Life Sciences</subject><subject>Care and treatment</subject><subject>Cerebrovascular diseases</subject><subject>Chronic kidney failure</subject><subject>Clinical outcomes</subject><subject>Comorbidity</subject><subject>Confidence intervals</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - mortality</subject><subject>COVID-19 - pathology</subject><subject>COVID-19 - virology</subject><subject>Creatinine</subject><subject>Cytokines</subject><subject>Diabetes mellitus</subject><subject>Dialysis</subject><subject>Education</subject><subject>End-stage renal disease</subject><subject>Female</subject><subject>Funding</subject><subject>Gender</subject><subject>Health risks</subject><subject>Health sciences</subject><subject>Hemodialysis</subject><subject>Hospital Mortality</subject><subject>Hospital patients</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Intensive care</subject><subject>Intensive Care Units</subject><subject>Internal medicine</subject><subject>Kidney diseases</subject><subject>Kidney transplantation</subject><subject>Kidneys</subject><subject>L-Lactate dehydrogenase</subject><subject>L-Lactate Dehydrogenase - blood</subject><subject>Lactate dehydrogenase</subject><subject>Lactic acid</subject><subject>Male</subject><subject>Males</subject><subject>Medical prognosis</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Nephrology</subject><subject>Observational studies</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Proportional Hazards Models</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Risk analysis</subject><subject>Risk Factors</subject><subject>SARS-CoV-2 - isolation &amp; purification</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Severity of Illness Index</subject><subject>Sex Factors</subject><subject>Software</subject><subject>Statistical analysis</subject><subject>Supervision</subject><subject>Turkey</subject><subject>University faculty</subject><subject>Viral diseases</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9uO0zAQhiMEYpfCGyCwhITgosWnuAkXSFU5VVqpEix7aznxpHE3jYvtIMpL8Mo4NLtq0F6gSHbifPOP57cnSZ4SPCNsTt5sbeda1cz2toUZpqnAlN1LzknO6FRQzO6fvJ8lj7zfYpyyTIiHyRnjbJ4yIc6T38taOVUGcMYHU3qkWo1sF0q7A49shVTZBUDXRrdwQKbddq6fUG393gTVmF-g0XJ9tXo_JTnaq2CgDf4tWqBd10TB-AUO-dDpAyoOKNSALjt3bXyNvC0NhEOfpIV97WxjN4fHyYNKNR6eDPMk-fbxw-Xy8_Ri_Wm1XFxMS5HTMAVNRSpyyAlL01IXBVGEkGyeEeAM5_MqIzQvNGiFK5FSTTGmFGdxUIrmImWT5PlRd99YLwcvvextxJzg6NwkWR0JbdVW7p3ZKXeQVhn5d8G6jVQuVtiAzBTkRUVVxSvgpNJFibkqIM855WlFi6j1bsjWFTvQvStONSPR8Z_W1HJjf8iMpZwLEQVeDQLOfu_AB7kzvoSmUS3Y7rhvmsczzSL64h_07uoGaqNiAaatbMxb9qJyIeaEM55hEqnZHVR8NOxMGS9eZeL6KOD1KCAyAX6Gjeq8l6uvX_6fXV-N2ZcnbA2qCbW3TReMbf0Y5EewdNZ7B9WtyQTLvm9u3JB938ihb2LYs9MDug26aRT2B12qE_4</recordid><startdate>20210810</startdate><enddate>20210810</enddate><creator>Arikan, Hakki</creator><creator>Ozturk, Savas</creator><creator>Tokgoz, Bulent</creator><creator>Dursun, Belda</creator><creator>Seyahi, Nurhan</creator><creator>Trabulus, Sinan</creator><creator>Islam, Mahmud</creator><creator>Ayar, Yavuz</creator><creator>Gorgulu, Numan</creator><creator>Karadag, Serhat</creator><creator>Gok, Mahmut</creator><creator>Akcali, Esra</creator><creator>Bora, Feyza</creator><creator>Aydın, Zeki</creator><creator>Altun, Eda</creator><creator>Ahbap, Elbis</creator><creator>Polat, Mehmet</creator><creator>Soypacacı, Zeki</creator><creator>Oguz, Ebru Gok</creator><creator>Koyuncu, Sumeyra</creator><creator>Colak, Hulya</creator><creator>Sahin, İdris</creator><creator>Dolarslan, Murside Esra</creator><creator>Helvacı, Ozant</creator><creator>Kurultak, Ilhan</creator><creator>Eren, Zehra</creator><creator>Dheir, Hamad</creator><creator>Ogutmen, Melike Betul</creator><creator>Taymez, Dilek Guven</creator><creator>Genek, Dilek Gibyeli</creator><creator>Ozkurt, Sultan</creator><creator>Bakır, Elif Ari</creator><creator>Yuksel, Enver</creator><creator>Sahutoglu, Tuncay</creator><creator>Oto, Ozgur Akin</creator><creator>Boz, Gulsah</creator><creator>Sengul, Erkan</creator><creator>Kara, Ekrem</creator><creator>Tuglular, Serhan</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4607-9220</orcidid><orcidid>https://orcid.org/0000-0002-1382-2439</orcidid><orcidid>https://orcid.org/0000-0003-1284-916X</orcidid><orcidid>https://orcid.org/0000-0003-0946-0823</orcidid><orcidid>https://orcid.org/0000-0001-6195-1932</orcidid></search><sort><creationdate>20210810</creationdate><title>Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology</title><author>Arikan, Hakki ; Ozturk, Savas ; Tokgoz, Bulent ; Dursun, Belda ; Seyahi, Nurhan ; Trabulus, Sinan ; Islam, Mahmud ; Ayar, Yavuz ; Gorgulu, Numan ; Karadag, Serhat ; Gok, Mahmut ; Akcali, Esra ; Bora, Feyza ; Aydın, Zeki ; Altun, Eda ; Ahbap, Elbis ; Polat, Mehmet ; Soypacacı, Zeki ; Oguz, Ebru Gok ; Koyuncu, Sumeyra ; Colak, Hulya ; Sahin, İdris ; Dolarslan, Murside Esra ; Helvacı, Ozant ; Kurultak, Ilhan ; Eren, Zehra ; Dheir, Hamad ; Ogutmen, Melike Betul ; Taymez, Dilek Guven ; Genek, Dilek Gibyeli ; Ozkurt, Sultan ; Bakır, Elif Ari ; Yuksel, Enver ; Sahutoglu, Tuncay ; Oto, Ozgur Akin ; Boz, Gulsah ; Sengul, Erkan ; Kara, Ekrem ; Tuglular, Serhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-ed26569e91355cdbb1a1118781e43097f8129bdeda0f652d2002208022aa29653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute Kidney Injury - etiology</topic><topic>Acute Kidney Injury - pathology</topic><topic>Age</topic><topic>Aged</topic><topic>Biology and Life Sciences</topic><topic>Care and treatment</topic><topic>Cerebrovascular diseases</topic><topic>Chronic kidney failure</topic><topic>Clinical outcomes</topic><topic>Comorbidity</topic><topic>Confidence intervals</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - mortality</topic><topic>COVID-19 - pathology</topic><topic>COVID-19 - virology</topic><topic>Creatinine</topic><topic>Cytokines</topic><topic>Diabetes mellitus</topic><topic>Dialysis</topic><topic>Education</topic><topic>End-stage renal disease</topic><topic>Female</topic><topic>Funding</topic><topic>Gender</topic><topic>Health risks</topic><topic>Health sciences</topic><topic>Hemodialysis</topic><topic>Hospital Mortality</topic><topic>Hospital patients</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Intensive care</topic><topic>Intensive Care Units</topic><topic>Internal medicine</topic><topic>Kidney diseases</topic><topic>Kidney transplantation</topic><topic>Kidneys</topic><topic>L-Lactate dehydrogenase</topic><topic>L-Lactate Dehydrogenase - blood</topic><topic>Lactate dehydrogenase</topic><topic>Lactic acid</topic><topic>Male</topic><topic>Males</topic><topic>Medical prognosis</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Nephrology</topic><topic>Observational studies</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Proportional Hazards Models</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Risk analysis</topic><topic>Risk Factors</topic><topic>SARS-CoV-2 - isolation &amp; purification</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Severity of Illness Index</topic><topic>Sex Factors</topic><topic>Software</topic><topic>Statistical analysis</topic><topic>Supervision</topic><topic>Turkey</topic><topic>University faculty</topic><topic>Viral diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arikan, Hakki</creatorcontrib><creatorcontrib>Ozturk, Savas</creatorcontrib><creatorcontrib>Tokgoz, Bulent</creatorcontrib><creatorcontrib>Dursun, Belda</creatorcontrib><creatorcontrib>Seyahi, Nurhan</creatorcontrib><creatorcontrib>Trabulus, Sinan</creatorcontrib><creatorcontrib>Islam, Mahmud</creatorcontrib><creatorcontrib>Ayar, Yavuz</creatorcontrib><creatorcontrib>Gorgulu, Numan</creatorcontrib><creatorcontrib>Karadag, Serhat</creatorcontrib><creatorcontrib>Gok, Mahmut</creatorcontrib><creatorcontrib>Akcali, Esra</creatorcontrib><creatorcontrib>Bora, Feyza</creatorcontrib><creatorcontrib>Aydın, Zeki</creatorcontrib><creatorcontrib>Altun, Eda</creatorcontrib><creatorcontrib>Ahbap, Elbis</creatorcontrib><creatorcontrib>Polat, Mehmet</creatorcontrib><creatorcontrib>Soypacacı, Zeki</creatorcontrib><creatorcontrib>Oguz, Ebru Gok</creatorcontrib><creatorcontrib>Koyuncu, Sumeyra</creatorcontrib><creatorcontrib>Colak, Hulya</creatorcontrib><creatorcontrib>Sahin, İdris</creatorcontrib><creatorcontrib>Dolarslan, Murside Esra</creatorcontrib><creatorcontrib>Helvacı, Ozant</creatorcontrib><creatorcontrib>Kurultak, Ilhan</creatorcontrib><creatorcontrib>Eren, Zehra</creatorcontrib><creatorcontrib>Dheir, Hamad</creatorcontrib><creatorcontrib>Ogutmen, Melike Betul</creatorcontrib><creatorcontrib>Taymez, Dilek Guven</creatorcontrib><creatorcontrib>Genek, Dilek Gibyeli</creatorcontrib><creatorcontrib>Ozkurt, Sultan</creatorcontrib><creatorcontrib>Bakır, Elif Ari</creatorcontrib><creatorcontrib>Yuksel, Enver</creatorcontrib><creatorcontrib>Sahutoglu, Tuncay</creatorcontrib><creatorcontrib>Oto, Ozgur Akin</creatorcontrib><creatorcontrib>Boz, Gulsah</creatorcontrib><creatorcontrib>Sengul, Erkan</creatorcontrib><creatorcontrib>Kara, Ekrem</creatorcontrib><creatorcontrib>Tuglular, Serhan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arikan, Hakki</au><au>Ozturk, Savas</au><au>Tokgoz, Bulent</au><au>Dursun, Belda</au><au>Seyahi, Nurhan</au><au>Trabulus, Sinan</au><au>Islam, Mahmud</au><au>Ayar, Yavuz</au><au>Gorgulu, Numan</au><au>Karadag, Serhat</au><au>Gok, Mahmut</au><au>Akcali, Esra</au><au>Bora, Feyza</au><au>Aydın, Zeki</au><au>Altun, Eda</au><au>Ahbap, Elbis</au><au>Polat, Mehmet</au><au>Soypacacı, Zeki</au><au>Oguz, Ebru Gok</au><au>Koyuncu, Sumeyra</au><au>Colak, Hulya</au><au>Sahin, İdris</au><au>Dolarslan, Murside Esra</au><au>Helvacı, Ozant</au><au>Kurultak, Ilhan</au><au>Eren, Zehra</au><au>Dheir, Hamad</au><au>Ogutmen, Melike Betul</au><au>Taymez, Dilek Guven</au><au>Genek, Dilek Gibyeli</au><au>Ozkurt, Sultan</au><au>Bakır, Elif Ari</au><au>Yuksel, Enver</au><au>Sahutoglu, Tuncay</au><au>Oto, Ozgur Akin</au><au>Boz, Gulsah</au><au>Sengul, Erkan</au><au>Kara, Ekrem</au><au>Tuglular, Serhan</au><au>Reboldi, Gianpaolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-08-10</date><risdate>2021</risdate><volume>16</volume><issue>8</issue><spage>e0256023</spage><pages>e0256023-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Acute kidney injury (AKI) is common in coronavirus disease-2019 (COVID-19) and the severity of AKI is linked to adverse outcomes. In this study, we investigated the factors associated with in-hospital outcomes among hospitalized patients with COVID-19 and AKI. In this multicenter retrospective observational study, we evaluated the characteristics and in-hospital renal and patient outcomes of 578 patients with confirmed COVID-19 and AKI. Data were collected from 34 hospitals in Turkey from March 11 to June 30, 2020. AKI definition and staging were based on the Kidney Disease Improving Global Outcomes criteria. Patients with end-stage kidney disease or with a kidney transplant were excluded. Renal outcomes were identified only in discharged patients. The median age of the patients was 69 years, and 60.9% were males. The most frequent comorbid conditions were hypertension (70.5%), diabetes mellitus (43.8%), and chronic kidney disease (CKD) (37.6%). The proportions of AKI stages 1, 2, and 3 were 54.0%, 24.7%, and 21.3%, respectively. 291 patients (50.3%) were admitted to the intensive care unit. Renal improvement was complete in 81.7% and partial in 17.2% of the patients who were discharged. Renal outcomes were worse in patients with AKI stage 3 or baseline CKD. The overall in-hospital mortality in patients with AKI was 38.9%. In-hospital mortality rate was not different in patients with preexisting non-dialysis CKD compared to patients without CKD (34.4 versus 34.0%, p = 0.924). By multivariate Cox regression analysis, age (hazard ratio [HR] [95% confidence interval (95%CI)]: 1.01 [1.0-1.03], p = 0.035], male gender (HR [95%CI]: 1.47 [1.04-2.09], p = 0.029), diabetes mellitus (HR [95%CI]: 1.51 [1.06-2.17], p = 0.022) and cerebrovascular disease (HR [95%CI]: 1.82 [1.08-3.07], p = 0.023), serum lactate dehydrogenase (greater than two-fold increase) (HR [95%CI]: 1.55 [1.05-2.30], p = 0.027) and AKI stage 2 (HR [95%CI]: 1.98 [1.25-3.14], p = 0.003) and stage 3 (HR [95%CI]: 2.25 [1.44-3.51], p = 0.0001) were independent predictors of in-hospital mortality. Advanced-stage AKI is associated with extremely high mortality among hospitalized COVID-19 patients. Age, male gender, comorbidities, which are risk factors for mortality in patients with COVID-19 in the general population, are also related to in-hospital mortality in patients with AKI. However, preexisting non-dialysis CKD did not increase in-hospital mortality rate among AKI patients. Renal problems continue in a significant portion of the patients who were discharged.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34375366</pmid><doi>10.1371/journal.pone.0256023</doi><tpages>e0256023</tpages><orcidid>https://orcid.org/0000-0003-4607-9220</orcidid><orcidid>https://orcid.org/0000-0002-1382-2439</orcidid><orcidid>https://orcid.org/0000-0003-1284-916X</orcidid><orcidid>https://orcid.org/0000-0003-0946-0823</orcidid><orcidid>https://orcid.org/0000-0001-6195-1932</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-08, Vol.16 (8), p.e0256023
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2560041019
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Acute Kidney Injury - etiology
Acute Kidney Injury - pathology
Age
Aged
Biology and Life Sciences
Care and treatment
Cerebrovascular diseases
Chronic kidney failure
Clinical outcomes
Comorbidity
Confidence intervals
Coronaviruses
COVID-19
COVID-19 - complications
COVID-19 - mortality
COVID-19 - pathology
COVID-19 - virology
Creatinine
Cytokines
Diabetes mellitus
Dialysis
Education
End-stage renal disease
Female
Funding
Gender
Health risks
Health sciences
Hemodialysis
Hospital Mortality
Hospital patients
Hospitalization
Hospitals
Humans
Hypertension
Intensive care
Intensive Care Units
Internal medicine
Kidney diseases
Kidney transplantation
Kidneys
L-Lactate dehydrogenase
L-Lactate Dehydrogenase - blood
Lactate dehydrogenase
Lactic acid
Male
Males
Medical prognosis
Medicine
Medicine and Health Sciences
Middle Aged
Mortality
Nephrology
Observational studies
Patient outcomes
Patients
Proportional Hazards Models
Regression analysis
Retrospective Studies
Risk analysis
Risk Factors
SARS-CoV-2 - isolation & purification
Severe acute respiratory syndrome coronavirus 2
Severity of Illness Index
Sex Factors
Software
Statistical analysis
Supervision
Turkey
University faculty
Viral diseases
title Characteristics and outcomes of acute kidney injury in hospitalized COVID-19 patients: A multicenter study by the Turkish society of nephrology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T13%3A11%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20outcomes%20of%20acute%20kidney%20injury%20in%20hospitalized%20COVID-19%20patients:%20A%20multicenter%20study%20by%20the%20Turkish%20society%20of%20nephrology&rft.jtitle=PloS%20one&rft.au=Arikan,%20Hakki&rft.date=2021-08-10&rft.volume=16&rft.issue=8&rft.spage=e0256023&rft.pages=e0256023-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0256023&rft_dat=%3Cgale_plos_%3EA671434801%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2560041019&rft_id=info:pmid/34375366&rft_galeid=A671434801&rft_doaj_id=oai_doaj_org_article_8ae9bf2af4fe41fdbc04abe994245f2b&rfr_iscdi=true